LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 CGP60474
0.04
uM
LJP6
 2
G06
 72
hr
 1476 1054 3694 0.2853 -0.1906
SK-BR-3 CGP60474
0.04
uM
LJP6
 3
G06
 72
hr
 1476 878 3694 0.2377 -0.2700
SK-BR-3 CHIR-99021
0.04
uM
LJP6
 1
P18
 72
hr
 1476 3012 3694 0.8154 0.6924
SK-BR-3 CHIR-99021
0.04
uM
LJP6
 2
P18
 72
hr
 1476 2770 3694 0.7499 0.5833
SK-BR-3 CHIR-99021
0.04
uM
LJP6
 3
P18
 72
hr
 1476 2747 3694 0.7436 0.5729
SK-BR-3 CP724714
0.04
uM
LJP5
 1
A12
 72
hr
 1476 2264 3694 0.6129 0.3551
SK-BR-3 CP724714
0.04
uM
LJP5
 2
A12
 72
hr
 1476 2265 3694 0.6132 0.3555
SK-BR-3 CP724714
0.04
uM
LJP5
 3
A12
 72
hr
 1476 2134 3694 0.5777 0.2964
SK-BR-3 CP466722
0.04
uM
LJP5
 1
I12
 72
hr
 1476 4520 3694 1.2236 1.3725
SK-BR-3 CP466722
0.04
uM
LJP5
 2
I12
 72
hr
 1476 4113 3694 1.1134 1.1889
SK-BR-3 CP466722
0.04
uM
LJP5
 3
I12
 72
hr
 1476 3934 3694 1.0650 1.1082
SK-BR-3 Crizotinib
0.04
uM
LJP5
 1
A24
 72
hr
 1476 2972 3694 0.8045 0.6744
SK-BR-3 Crizotinib
0.04
uM
LJP5
 2
A24
 72
hr
 1476 2839 3694 0.7685 0.6144
SK-BR-3 Crizotinib
0.04
uM
LJP5
 3
A24
 72
hr
 1476 2801 3694 0.7583 0.5972
SK-BR-3 Momelotinib
0.04
uM
LJP5
 1
P12
 72
hr
 1476 3173 3694 0.8590 0.7650
SK-BR-3 Momelotinib
0.04
uM
LJP5
 2
P12
 72
hr
 1476 2998 3694 0.8116 0.6861
SK-BR-3 Momelotinib
0.04
uM
LJP5
 3
P12
 72
hr
 1476 2771 3694 0.7501 0.5837
SK-BR-3 Dasatinib
0.04
uM
LJP5
 1
D06
 72
hr
 1476 3682 3694 0.9967 0.9946
SK-BR-3 Dasatinib
0.04
uM
LJP5
 2
D06
 72
hr
 1476 3762 3694 1.0184 1.0306
SK-BR-3 Dasatinib
0.04
uM
LJP5
 3
D06
 72
hr
 1476 3747 3694 1.0143 1.0239
SK-BR-3 Dasatinib
0.04
uM
LJP6
 1
I06
 72
hr
 1476 3730 3694 1.0097 1.0162
SK-BR-3 Dasatinib
0.04
uM
LJP6
 2
I06
 72
hr
 1476 4128 3694 1.1175 1.1957
SK-BR-3 Dasatinib
0.04
uM
LJP6
 3
I06
 72
hr
 1476 3329 3694 0.9012 0.8354
SK-BR-3 Dovitinib
0.04
uM
LJP5
 1
E24
 72
hr
 1476 3162 3694 0.8560 0.7601
SK-BR-3 Dovitinib
0.04
uM
LJP5
 2
E24
 72
hr
 1476 2719 3694 0.7361 0.5603